{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:54:07Z","timestamp":1791982447065,"version":"4.4.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.amjcard.2026.08.027","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:32:53Z","timestamp":1788478373000},"page":"70-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early Low-Density Lipoprotein Cholesterol Target Attainment Is Associated With Fewer Recurrent Cardiovascular Events After Acute Myocardial Infarction: A Real-World Cohort Study"],"prefix":"10.1016","volume":"278","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7844-4491","authenticated-orcid":false,"given":"Henry","family":"Okoroike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4015-0420","authenticated-orcid":false,"given":"Ahmet Afsin","family":"Oktay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.amjcard.2026.08.027_bib0001","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/clc.23773","article-title":"Early and late recurrent cardiovascular events among high-risk patients with acute coronary syndrome: meta-analysis of phase III studies","volume":"45","author":"Chi","year":"2022","journal-title":"Clin Cardiol"},{"issue":"18","key":"10.1016\/j.amjcard.2026.08.027_bib0002","article-title":"Event rates and risk factors for recurrent cardiovascular events in a contemporary post-ACS population in the United States","volume":"11","author":"Steen","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"10.1016\/j.amjcard.2026.08.027_bib0003","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/eurheartj\/ehu505","article-title":"Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective","volume":"36","author":"Jernberg","year":"2015","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.amjcard.2026.08.027_bib0004","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2018.2525","article-title":"Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis","volume":"319","author":"Navarese","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.amjcard.2026.08.027_bib0005","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"issue":"32","key":"10.1016\/j.amjcard.2026.08.027_bib0006","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: evidence from genetic, epidemiologic, and clinical studies","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.amjcard.2026.08.027_bib0007","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation."},{"issue":"22","key":"10.1016\/j.amjcard.2026.08.027_bib0008","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.amjcard.2026.08.027_bib0009","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"IMPROVE-IT Investigators. Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.08.027_bib0010","doi-asserted-by":"crossref","first-page":"100624","DOI":"10.1016\/j.lanepe.2023.100624","article-title":"Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study","volume":"29","author":"Ray","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"10.1016\/j.amjcard.2026.08.027_bib0011","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jacl.2021.11.001","article-title":"Factors associated with time to initiation of a PCSK9 inhibitor after hospital discharge for acute myocardial infarction","volume":"16","author":"McKinley","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"4","key":"10.1016\/j.amjcard.2026.08.027_bib0012","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.006646","article-title":"Lipid testing, lipid-modifying therapy, and PCSK9 inhibitor eligibility in 27 979 patients with incident acute coronary syndrome","volume":"14","author":"Sarak","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.amjcard.2026.08.027_bib0013","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jacl.2020.04.004","article-title":"Effect of pharmacist interventions on reducing LDL-C levels: a systematic review and meta-analysis","volume":"14","author":"Dixon","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.amjcard.2026.08.027_bib0014","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/j.1875-9114.2012.01022.x","article-title":"A systematic review of the evidence for pharmacist care of patients with dyslipidemia","volume":"32","author":"Charrois","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.amjcard.2026.08.027_bib0015","doi-asserted-by":"crossref","first-page":"102075","DOI":"10.1016\/j.jacadv.2025.102075","article-title":"Impact of a meds-to-beds PCSK9 inhibitor initiation program on LDL-C in patients undergoing ASCVD revascularization","volume":"4","author":"Lorenzatti","year":"2025","journal-title":"JACC Adv"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926005497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926005497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:33:01Z","timestamp":1791981181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914926005497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":15,"alternative-id":["S0002914926005497"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.08.027","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Low-Density Lipoprotein Cholesterol Target Attainment Is Associated With Fewer Recurrent Cardiovascular Events After Acute Myocardial Infarction: A Real-World Cohort Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}